...
首页> 外文期刊>Acta biomaterialia >Xenogeneic cardiac extracellular matrix scaffolds with or without seeded mesenchymal stem cells exhibit distinct in vivo immunosuppressive and regenerative properties
【24h】

Xenogeneic cardiac extracellular matrix scaffolds with or without seeded mesenchymal stem cells exhibit distinct in vivo immunosuppressive and regenerative properties

机译:具有或不具有间充质干细胞的异种心脏细胞外基质支架均具有独特的体内免疫抑制和再生特性

获取原文
获取原文并翻译 | 示例
           

摘要

Cardiac extracellular matrix (cECM) scaffolds are promising biomaterials for reconstructive surgery applications since they possess the structure/function properties of native tissue. Production of cECM scaffolds has been achieved using decellularization approaches, which commonly employ denaturing detergents, such as sodium dodecyl sulfate (SDS). Our antigen removal (AR) method has been shown to remove cellular and nonmyocyte components, while preserving cECM scaffold structure/function relationships. Here, we demonstrate that more human mesenchymal stem cells (MSCs) invaded AR scaffolds compared to SDS controls. Additionally, AR scaffolds stimulated a constructive remodeling response similar to allograft controls, and were transformed to adipose tissue in a xenogeneic rat to mouse subpannicular in vivo model. Conversely, SDS scaffolds showed a chronic inflammatory response that worsened throughout the 12-wk time course preventing constructive remodeling and mirroring the response seen towards xenogeneic tissue. AR scaffolds and xenogeneic controls recellularized with murine MSCs (mMSCs) were also implanted to assess whether mMSCs would offer any additive benefit in overcoming residual scaffold specific immune responses. Paradoxically, recellularization resulted in chronic inflammatory response in AR-recellularized scaffolds. We conclude that AR cECM scaffolds represent a promising biomaterial, which is accepted by the recipient as self in origin and fosters implantation site appropriate regenerative responses.
机译:心脏细胞外基质(cECM)支架是有前途的生物材料,可用于重建手术,因为它们具有天然组织的结构/功能特性。使用脱细胞方法已经实现了cECM支架的生产,该方法通常采用变性去污剂,例如十二烷基硫酸钠(SDS)。我们的抗原去除(AR)方法已显示去除细胞和非肌细胞成分,同时保留cECM支架的结构/功能关系。在这里,我们证明,与SDS对照相比,更多的人类间充质干细胞(MSC)入侵AR支架。此外,AR支架刺激了与同种异体移植控件相似的建设性重塑反应,并被转化为异种大鼠至小鼠圆锥下体内模型的脂肪组织。相反,SDS支架显示出慢性炎症反应,在整个12周的时间过程中恶化,阻止了结构性重塑并反映了对异种组织的反应。还植入了用鼠MSC(mMSC)重新细胞化的AR支架和异种对照,以评估mMSC在克服残留支架特异性免疫反应方面是否会提供任何附加益处。矛盾的是,再细胞化导致AR-再细胞化的支架发生慢性炎症反应。我们得出的结论是,AR cECM支架代表了一种有前途的生物材料,被受体接受为自身起源,并促进了植入部位适当的再生反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号